封面
市場調查報告書
商品編碼
1762354

高分子藥物研發外包市場,規模,佔有率,產業分析報告:各類服務,工作流程,各治療領域,各最終用途,各地區,2025年~2034年的市場預測

Large Molecule Drug Discovery Outsourcing Market Size, Share, & Industry Analysis Report: By Service (Chemistry Services and Biology Services), By Workflow, By Therapeutics Area, By End Use, and By Region - Market Forecast, 2025-2034

出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究,預計到2034年,聚合物藥物發現外包市場規模將達到65.3億美元。該報告深入分析了當前的市場動態,並分析了未來的市場成長。

聚合物藥物發現外包是指將早期生物研究活動(例如標靶驗證、關鍵標靶識別和候選藥物優化)外包給專業的外部合作夥伴,以提高效率和創新能力。生物製劑和新型療法日益受到關注,這需要公司內部難以獲得的專業能力,這進一步支持了其成長機會。隨著生物製藥公司尋求加速單株抗體、融合蛋白和核酸類藥物等複雜聚合物的研發,將研發工作外包給擁有合適技術和科研專長的合約研究組織 (CRO) 已成為策略上的必然選擇。這種方法可以優化資源利用率,縮短早期發現時間,同時維持較高的科學標準。

人工智慧驅動的藥物發現、生物資訊學和高通量篩選平台等先進技術日益融入外包模式,正在塑造聚合物藥物發現外包市場的需求。這些工具改進了數據分析、預測模型和分子設計,使 CRO 能夠提供更精準、更有效率的藥物發現流程。隨著生物製劑領域競爭的加劇,企業越來越重視能夠提供更快週轉時間、更深入的生物機制洞察以及更高識別可行候選藥物可能性的技術支援型合作夥伴。這種向技術驅動型外包合作的轉變預計將重新定義聚合物藥物發現領域的創新速度和品質。

聚合物藥物發現外包市場報告重點

按工作流程劃分,先導化合物鑑定和候選化合物優化細分市場在2024年佔據了最大的市場佔有率。這是因為這些細分市場在純化先導化合物以確保生物製劑開發中的最佳療效、安全性和類藥特性方面發揮關鍵作用。

按服務劃分,化學服務細分市場預計將顯著擴張,這得益於改善聚合物藥物候選化合物的結構完整性、穩定性和功能性的重要性。

2024年,北美將佔據最大的收入佔有率,這得益於其成熟的生物製藥行業、強勁的研發投入以及強大的生物製劑研究機構網絡。

在預測期內,亞太地區的聚合物藥物發現外包市場預計將快速成長,這得益於外包業務的成長。需求、成本優勢以及專門從事生物製劑研究的開發基礎設施。

全球主要的市場開發公司包括 Charles River Laboratories、Dalton Pharma Services、Domainex、Eurofins Discovery、Evotec SE、GenScript、Jubilant Biosys Limited、Labcorp.(Covance)、Merck &Co. Inc.、Pharmaceutical Product Development, LLC(PPD,賽默飛世爾科技公司) Ltd. 和藥明康德。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球高分子藥物研發外包市場洞察

  • 市場概述
  • 高分子藥物研發外包市場動態
    • 促進因素和機會
      • 不斷增加的合作夥伴關係和基於平台的合作
      • 藥物發現技術的進步
    • 限制與課題
      • 關稅導致供應鏈中斷和成本上升
  • PESTEL分析
  • 高分子藥物研發外包市場趨勢
  • 價值鏈分析

第5章 按全球高分子藥物研發外包市場:工作流程

  • 主要調查結果
  • 簡介
  • 目標的特定和篩檢
  • 與目標檢驗功能資訊科學
  • 領導特定和候選人最佳化
  • 前臨床開發
  • 其他

第6章 全球高分子藥物研發外包市場:各類服務

  • 主要調查結果
  • 簡介
  • 化學服務
  • 生物學服務

第7章 全球高分子藥物研發外包市場:各治療領域

  • 主要調查結果
  • 簡介
  • 呼吸系統
  • 疼痛與麻醉
  • 腫瘤學
  • 眼科
  • 血液學
  • 其他

第8章 全球高分子藥物研發外包市場:各最終用途

  • 主要調查結果
  • 簡介
  • 醫藥品·生物科技
  • 學術機構

第9章 全球高分子藥物研發外包市場:各地區

  • 主要調查結果
  • 簡介
    • 高分子藥物研發外包市場分析:各地區,2020~2034年
  • 北美
    • 北美:工作流程,2020~2034年
    • 北美:各類服務,2020~2034年
    • 北美:各治療領域,2020~2034年
    • 北美:各最終用途,2020~2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:工作流程,2020~2034年
    • 歐洲:各類服務,2020~2034年
    • 歐洲:各治療領域,2020~2034年
    • 歐洲:各最終用途,2020~2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:工作流程,2020~2034年
    • 亞太地區:各類服務,2020~2034年
    • 亞太地區:各治療領域,2020~2034年
    • 亞太地區:各最終用途,2020~2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:工作流程,2020~2034年
    • 中東·非洲:各類服務,2020~2034年
    • 中東·非洲:各治療領域,2020~2034年
    • 中東·非洲:各最終用途,2020~2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲
  • 南美
    • 南美:工作流程,2020~2034年
    • 南美:各類服務,2020~2034年
    • 南美:各治療領域,2020~2034年
    • 南美:各最終用途,2020~2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第10章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第11章 企業簡介

  • Charles River Laboratories
  • Dalton Pharma Services
  • Domainex
  • Eurofins Discovery
  • Evotec SE
  • GenScript
  • Jubilant Biosys Limited
  • Labcorp.(Covance)
  • Labcorp.(Covance)
  • Pharmaceutical Product Development, LLC(PPD, part of Thermo Fisher)
  • Pharmaron
  • QIAGEN
  • Syngene International Limited
  • TCG Lifesciences Pvt Ltd.
  • WuXi AppTec
Product Code: PM5755

The large molecule drug discovery outsourcing market size is expected to reach USD 6.53 billion by 2034, according to a new study by Polaris Market Research. The report "Large Molecule Drug Discovery Outsourcing Market Share, Size, Trends, Industry Analysis Report By Service (Chemistry Services and Biology Services), By Workflow, By Therapeutics Area, By End Use, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Large molecule drug discovery outsourcing refers to the delegation of early-stage biologic research activities, such as target validation, HIT identification, and candidate optimization to specialized external partners to improve efficiency and innovation. The increasing focus on biologics and novel therapeutic modalities, which demand specialized capabilities not readily available in house, further contributes to the growth opportunities. Outsourcing to contract research organizations (CROs) with the right technological and scientific expertise has become a strategic necessity as biopharmaceutical companies seek to accelerate the development of complex large molecules such as monoclonal antibodies, fusion proteins, and nucleic acid-based drugs. This approach optimizes resource utilization and reduces early-stage discovery timelines while maintaining high scientific standards.

The growing integration of advanced technologies such as AI-driven drug discovery, bioinformatics, and high-throughput screening platforms into outsourcing models shapes the large molecule drug discovery outsourcing market demand. These tools improve data analysis, predictive modeling, and molecular design, encouraging CROs to offer more precise and efficient discovery processes. Companies are increasingly prioritizing technology-enabled partners who provide faster turnaround, deeper insight into biological mechanisms, and a higher chance of identifying feasible drug candidates as competition increases in the biologics space. This shift toward tech-driven outsourcing partnerships is expected to redefine the pace and quality of innovation across the large-molecule drug discovery landscape.

Large Molecule Drug Discovery Outsourcing Market Report Highlights

In terms of workflow, the lead identification and candidate optimization segment held the largest market share in 2024, owing to its critical role in refining lead compounds to ensure optimal therapeutic efficacy, safety, and drug-like properties for biologics development.

Based on service, the chemistry services segment is poised for notable expansion, fueled by its importance in enhancing the structural integrity, stability, and functionality of large-molecule drug candidates.

In 2024, North America accounted for the largest revenue share, supported by its mature biopharmaceutical industry, strong R&D investments, and a robust network of biologics-focused research organizations.

The Asia Pacific large molecule drug discovery outsourcing market is anticipated to experience rapid growth during the forecast period, driven by rising outsourcing demand, cost advantages, and the increasing establishment of specialized biologics research infrastructure.

A few global key market players include Charles River Laboratories; Dalton Pharma Services; Domainex; Eurofins Discovery; Evotec SE; GenScript; Jubilant Biosys Limited; Labcorp. (Covance); Merck & Co., Inc.; Pharmaceutical Product Development, LLC (PPD, part of Thermo Fisher); Pharmaron; QIAGEN; Syngene International Limited; TCG Lifesciences Pvt Ltd.; and WuXi AppTec.

Polaris Market Research has segmented the large molecule drug discovery outsourcing market report on the basis of workflow, service, therapeutics area, end use, and region:

By Workflow Outlook (Revenue, USD Billion, 2020-2034)

Target Identification & Screening

Target Validation & Functional Informatics

Lead Identification & Candidate Optimization

Preclinical Development

Others

By Service Outlook (Revenue, USD Billion, 2020-2034)

Chemistry Services

Biology Services

By Therapeutics Area Outlook (Revenue, USD Billion, 2020-2034)

Respiratory system

Pain and Anesthesia

Oncology

Ophthalmology

Hematology

Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Pharmaceutical & Biotechnology

Academic Institutes

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of the Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Large Molecule Drug Discovery Outsourcing Market Insights

  • 4.1. Large Molecule Drug Discovery Outsourcing Market - Market Snapshot
  • 4.2. Large Molecule Drug Discovery Outsourcing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Partnerships and Platform-Based Collaboration
      • 4.2.1.2. Increasing Advancements in Drug Discovery Technology
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Supply chain disruptions and increased costs due to tariffs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Large Molecule Drug Discovery Outsourcing Market Trends
  • 4.6. Value Chain Analysis

5. Global Large Molecule Drug Discovery Outsourcing Market, by Workflow

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • 5.3. Target Identification & Screening
    • 5.3.1. Global Large Molecule Drug Discovery Outsourcing Market, by Target Identification & Screening, by Region, 2020-2034 (USD Billion)
  • 5.4. Target Validation & Functional Informatics
    • 5.4.1. Global Large Molecule Drug Discovery Outsourcing Market, by Target Validation & Functional Informatics, by Region, 2020-2034 (USD Billion)
  • 5.5. Lead Identification & Candidate Optimization
    • 5.5.1. Global Large Molecule Drug Discovery Outsourcing Market, by Lead Identification & Candidate Optimization, by Region, 2020-2034 (USD Billion)
  • 5.6. Preclinical Development
    • 5.6.1. Global Large Molecule Drug Discovery Outsourcing Market, by Preclinical Development, by Region, 2020-2034 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Large Molecule Drug Discovery Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Large Molecule Drug Discovery Outsourcing Market, by Service

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • 6.3. Chemistry Services
    • 6.3.1. Global Large Molecule Drug Discovery Outsourcing Market, by Chemistry Services, by Region, 2020-2034 (USD Billion)
  • 6.4. Biology Services
    • 6.4.1. Global Large Molecule Drug Discovery Outsourcing Market, by Biology Services, by Region, 2020-2034 (USD Billion)

7. Global Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Large Molecule Drug Discovery Outsourcing Market, by Respiratory system, 2020-2034 (USD Billion)
  • 7.3. Respiratory system
    • 7.3.1. Global Large Molecule Drug Discovery Outsourcing Market, by Pharmaceuticals & Biotechnology, by Region, 2020-2034 (USD Billion)
  • 7.4. Pain and Anesthesia
    • 7.4.1. Global Large Molecule Drug Discovery Outsourcing Market, by Pain and Anesthesia, by Region, 2020-2034 (USD Billion)
  • 7.5. Oncology
    • 7.5.1. Global Large Molecule Drug Discovery Outsourcing Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 7.6. Ophthalmology
    • 7.6.1. Global Large Molecule Drug Discovery Outsourcing Market, by Ophthalmology, by Region, 2020-2034 (USD Billion)
  • 7.7. Hematology
    • 7.7.1. Global Large Molecule Drug Discovery Outsourcing Market, by Hematology, by Region, 2020-2034 (USD Billion)
  • 7.8. Others
    • 7.8.1. Global Large Molecule Drug Discovery Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Large Molecule Drug Discovery Outsourcing Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 8.3. Pharmaceuticals & Biotechnology
    • 8.3.1. Global Large Molecule Drug Discovery Outsourcing Market, by Pharmaceuticals & Biotechnology, by Region, 2020-2034 (USD Billion)
  • 8.4. Academic Institutes
    • 8.4.1. Global Large Molecule Drug Discovery Outsourcing Market, by Academic Institutes, by Region, 2020-2034 (USD Billion)

9. Global Large Molecule Drug Discovery Outsourcing Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Large Molecule Drug Discovery Outsourcing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Large Molecule Drug Discovery Outsourcing Market - North America
    • 9.3.1. North America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.3.2. North America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.3.3. North America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.3.4. North America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.5. Large Molecule Drug Discovery Outsourcing Market - US
      • 9.3.5.1. US: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.6. Large Molecule Drug Discovery Outsourcing Market - Canada
      • 9.3.6.1. Canada: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.4. Large Molecule Drug Discovery Outsourcing Market - Europe
    • 9.4.1. Europe: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.5. Large Molecule Drug Discovery Outsourcing Market - UK
      • 9.4.5.1. UK: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.6. Large Molecule Drug Discovery Outsourcing Market - France
      • 9.4.6.1. France: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.7. Large Molecule Drug Discovery Outsourcing Market - Germany
      • 9.4.7.1. Germany: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.8. Large Molecule Drug Discovery Outsourcing Market - Italy
      • 9.4.8.1. Italy: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.9. Large Molecule Drug Discovery Outsourcing Market - Spain
      • 9.4.9.1. Spain: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.10. Large Molecule Drug Discovery Outsourcing Market - Netherlands
      • 9.4.10.1. Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.11. Large Molecule Drug Discovery Outsourcing Market - Russia
      • 9.4.11.1. Russia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.12. Large Molecule Drug Discovery Outsourcing Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.5. Large Molecule Drug Discovery Outsourcing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.5. Large Molecule Drug Discovery Outsourcing Market - China
      • 9.5.5.1. China: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.6. Large Molecule Drug Discovery Outsourcing Market - India
      • 9.5.6.1. India: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.7. Large Molecule Drug Discovery Outsourcing Market - Malaysia
      • 9.5.7.1. Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.8. Large Molecule Drug Discovery Outsourcing Market - Japan
      • 9.5.8.1. Japan: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.9. Large Molecule Drug Discovery Outsourcing Market - Indonesia
      • 9.5.9.1. Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.10. Large Molecule Drug Discovery Outsourcing Market - South Korea
      • 9.5.10.1. South Korea: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.11. Large Molecule Drug Discovery Outsourcing Market - Australia
      • 9.5.11.1. Australia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.12. Large Molecule Drug Discovery Outsourcing Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.6. Large Molecule Drug Discovery Outsourcing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.5. Large Molecule Drug Discovery Outsourcing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.6. Large Molecule Drug Discovery Outsourcing Market - UAE
      • 9.6.6.1. UAE: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.7. Large Molecule Drug Discovery Outsourcing Market - Israel
      • 9.6.7.1. Israel: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.8. Large Molecule Drug Discovery Outsourcing Market - South Africa
      • 9.6.8.1. South Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.9. Large Molecule Drug Discovery Outsourcing Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.7. Large Molecule Drug Discovery Outsourcing Market - Latin America
    • 9.7.1. Latin America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.5. Large Molecule Drug Discovery Outsourcing Market - Mexico
      • 9.7.5.1. Mexico: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.6. Large Molecule Drug Discovery Outsourcing Market - Brazil
      • 9.7.6.1. Brazil: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.7. Large Molecule Drug Discovery Outsourcing Market - Argentina
      • 9.7.7.1. Argentina: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.8. Large Molecule Drug Discovery Outsourcing Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Charles River Laboratories
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Dalton Pharma Services
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Domainex
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Eurofins Discovery
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Evotec SE
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. GenScript
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Jubilant Biosys Limited
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Labcorp. (Covance)
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Labcorp. (Covance)
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Pharmaceutical Product Development, LLC (PPD, part of Thermo Fisher)
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Pharmaron
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. QIAGEN
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Syngene International Limited
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. TCG Lifesciences Pvt Ltd.
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. WuXi AppTec
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development

List of Tables:

  • Table 1 Global Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 2 Global Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 3 Global Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 4 Global Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 5 North America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 6 North America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 7 North America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 8 North America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 9 US: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 10 US: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 11 US: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 12 US: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Canada: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 14 Canada: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 15 Canada: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 16 Canada: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 17 Europe: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 18 Europe: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 19 Europe: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 20 Europe: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 21 UK: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 22 UK: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 23 UK: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 24 UK: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 France: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 26 France: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 27 France: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 28 France: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 29 Germany: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 30 Germany: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 31 Germany: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 32 Germany: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 33 Italy: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 34 Italy: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 35 Italy: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 36 Italy: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Spain: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 38 Spain: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 39 Spain: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 40 Spain: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 45 Russia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 46 Russia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 47 Russia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 48 Russia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 57 China: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 58 China: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 59 China: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 60 China: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 India: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 62 India: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 63 India: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 64 India: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 69 Japan: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 70 Japan: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 71 Japan: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 72 Japan: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 77 South Korea: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 78 South Korea: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 79 South Korea: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 80 South Korea: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 81 Australia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 82 Australia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 83 Australia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 84 Australia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 UAE: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 98 UAE: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 99 UAE: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 100 UAE: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 101 Israel: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 102 Israel: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 103 Israel: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 104 Israel: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 105 South Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 106 South Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 107 South Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 108 South Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 113 Latin America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 114 Latin America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 115 Latin America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 116 Latin America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 117 Mexico: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 118 Mexico: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 119 Mexico: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 120 Mexico: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 121 Brazil: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 122 Brazil: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 123 Brazil: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 124 Brazil: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 125 Argentina: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 126 Argentina: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 127 Argentina: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 128 Argentina: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Large Molecule Drug Discovery Outsourcing Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Workflow
  • Figure 7. Global Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Service
  • Figure 9. Global Large Molecule Drug Discovery Outsourcing Market, by Service, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Therapeutics Area
  • Figure 11. Global Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2024 & 2034 (USD Billion)
  • Figure 12. Market by End Use
  • Figure 13. Global Large Molecule Drug Discovery Outsourcing Market, by End Use, 2024 & 2034 (USD Billion)
  • Figure 14. Global Large Molecule Drug Discovery Outsourcing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • Figure 15. Strategic Analysis - Global Large Molecule Drug Discovery Outsourcing Market